-
Kenya's economy faces climate change risks: World Bank
-
Between Trump and a hard place: Fed chair Warsh to lead first rate meeting
-
High-school drop out to big time crime boss, Venezuela's 'Nino Guerrero'
-
US-Iran deal could be finalised soon, mediator Pakistan says
-
Thousands gather in Thai capital to mourn late princess
-
US says downed multiple Iran drones as both insist deal closer
-
SpaceX: Five key moments, from first launch to Starship megarocket
-
US clears Paramount's $111 bn Warner Bros. takeover
-
Iran and US say deal closer than ever
-
Cuba opens more sectors to private business
-
World Cup struggles to ignite US excitement
-
US appellate court upholds Sam Bankman-Fried criminal sentence
-
France bids farewell to girl, 11, whose killing sparked outrage
-
Wall Street wobbles as SpaceX shares launch, oil slides on Mideast deal hopes
-
SpaceX lifts off in record Wall Street debut
-
US deportation flight carrying Iranians en route to C.African Republic
-
At a Libyan university once ravaged by war, students dream again
-
Kenya mourns schoolgirls killed in suspected dorm arson attack
-
Stocks rally, oil slides on Mideast deal hopes
-
'All of us of are migrants,' pope says in Canary Islands
-
Switzerland split on immigration vote: four perspectives
-
Thai princess dies aged 47 after three years in hospital
-
Science fiction? Musk's lofty SpaceX goals unrealistic, skeptics say
-
Asia stocks up, oil down on Mideast deal hopes
-
From cage fights to the White House, UFC marches into mainstream
-
Pope ends Spain visit with migrant meetings
-
Ex-Tottenham owner sells art collection in blockbuster auction
-
Antarctic Peninsula sees record high June temperatures
-
US stocks rally, oil prices fall as Trump calls off fresh Iran strikes
-
SpaceX to make historic IPO that could make Musk a trillionaire
-
El Nino is back, but its effects vary widely
-
First leather bag from T-Rex cells to be auctioned in Paris
-
Four times as many icebergs calved from Greenland glaciers: study
-
Stocks rebound, oil wavers as traders weigh Iran, rates outlook
-
Niger criminalises same-sex relations with jail terms
-
Smuggled dinosaur fossils return to Mongolia after two decades
-
Over 260 Nigerians fleeing xenophobic attacks in S. Africa return home
-
Pope condemns 'indifference' towards migrants on Canaries trip
-
Sweden withdraws controversial proposal to jail 13-year-olds
-
Economic pressures 'manageable': Indonesian deputy finance minister
-
Scientists warn of record heat, threats to climate monitoring
-
Sweden withdraws disputed proposal to jail 13-year-olds
-
UK probes Ryanair over fees for parents to sit with children
-
Suspense surrounds Swiss anti-immigration vote
-
Rising costs and competition threaten GoPro
-
A taste of home: Zimbabwe restaurants revive traditional food
-
AI gold rush upends San Francisco housing market
-
The Indian workers training AI robots to take their jobs
-
AI robot cleaners leave the lab for China's living rooms
-
In ageing South Korea, AI dolls care for the elderly
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
Y.Ponomarenko--CPN